Sonoma Biotherapeutics Appoints Rajesh Krishnan, Ph.D., as Chief Technical Officer [Yahoo! Finance]
Dynavax Technologies Corporation (DVAX)
Last dynavax technologies corporation earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dynavax.com
Company Research
Source: Yahoo! Finance
engineered regulatory T cell (Treg) therapies for autoimmune and inflammatory diseases, today announced the appointment of Rajesh Krishnan, Ph.D., to the company's executive management team as Chief Technical Officer (CTO). Dr. Krishnan joins Sonoma Biotherapeutics with over 25 years of industry experience in process development and manufacturing, most recently having served as CTO and CSO of Oncternal Therapeutics. "Raj brings to Sonoma Biotherapeutics a wealth of global pharmaceutical product development and manufacturing experience. His proven leadership, particularly in cell therapy, will be instrumental as we continue to advance engineered regulatory T cell (Treg) therapies," said Jeff Bluestone, Ph.D., Chief Executive Officer and President of Sonoma Biotherapeutics. "We are pleased to have Raj join us as we continue to advance our pipeline of potentially novel treatments for serious autoimmune and inflammatory diseases." Dr. Krishnan has more than two decades of experience d
Show less
Read more
Impact Snapshot
Event Time:
DVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVAX alerts
High impacting Dynavax Technologies Corporation news events
Weekly update
A roundup of the hottest topics
DVAX
News
- CDC vaccine panel set to debate hepatitis b shots, childhood immunizations [Seeking Alpha]Seeking Alpha
- Dynavax to Participate at the 8th Annual Evercore Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Dynavax to Participate at the 8th Annual Evercore Healthcare ConferencePR Newswire
- Vaxart Inc (VXRT) Q3 2025 Earnings Call Highlights: Strategic Partnership and Revenue Surge ... [Yahoo! Finance]Yahoo! Finance
- Vaxart extends cash runway into Q2 2027 with Dynavax partnership and targets 2026 data readouts [Seeking Alpha]Seeking Alpha
DVAX
Earnings
- 11/5/25 - Beat
DVAX
Sec Filings
- 11/5/25 - Form 10-Q
- 11/5/25 - Form 8-K
- 10/16/25 - Form 8-K
- DVAX's page on the SEC website